Vaccine Scheduler
Netherlands: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Months | Years | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 3 | 5 | 6 | 12 | 14 | 3 | 4 | 5 | 9 | 10 | 14 | 18 | ||||
| Coronavirus disease (COVID-19) | COVID-191 | |||||||||||||||
| tuberculosis | BCG2 | |||||||||||||||
| rotavirus infection | ROTA | ROTA | ||||||||||||||
| diphtheria | D3 | D | D | D | D4 | D5 | d6 | |||||||||
| tetanus | TT3 | TT | TT | TT | TT4 | TT5 | TT6 | |||||||||
| pertussis | acP3 | acP | acP | acP | acP4 | acp6 | ||||||||||
| poliomyelitis | IPV3 | IPV | IPV | IPV | IPV5 | |||||||||||
| Haemophilus influenzae type b infection | Hib3 | Hib | Hib | Hib | ||||||||||||
| hepatitis B | HepB7 | HepB3 | HepB | HepB | HepB | |||||||||||
| pneumococcal disease | PCV15 | PCV15 | PCV15 | |||||||||||||
| meningococcal disease | MCV48 | MCV48 | ||||||||||||||
| measles | MEAS | MEAS | MEAS9 | |||||||||||||
| mumps | MUMPS | MUMPS | MUMPS9 | |||||||||||||
| rubella | RUBE | RUBE | RUBE9 | |||||||||||||
| human papillomavirus infection | HPV2 (F/M) | |||||||||||||||
| influenza | IIV10 | |||||||||||||||
Version:
Footnotes:
- Recommended to individuals in medical high risk groups aged 6 months and older (https://lci.rivm.nl/richtlijnen/covid-19-vaccinatie#2-vaccinatiestrategie-covid-19)
- Only given on specific indications. More information available at: https://www.rivm.nl/cpt/richtlijnen-preventie/bcg-vaccinatie
- This additional vaccination is recommended only for infants at 2 months of age whose mothers were not vaccinated during pregnancy, and in specific circumstances. In all other cases, infants born to mothers vaccinated during pregnancy (at 22 weeks gestation) receive a two-dose primary series at 3 and 5 months of age.
- starting cohort 2021
- starting cohort 2016
- Recommended for pregnant women from the 22nd weeks of pregnancy until delivery (in every pregnancy)
- Offered to infants born to a mother infected with hepatitis B
- Also prescribed to medical high risk groups of other ages by the attending medical doctor and reimbursed by the health insurer (https://lci.rivm.nl/factsheets/meningokokken-acwy-vaccinatie)
- Following shift of MMR vaccine from 9 to 3 years old in 2025, a catch up campaign is in place for cohorts 2016 to 2021 between 2025-27
- Indicated to individuals in medical high risk groups of 6 months of age and older and in pregnant women. More information available at: https://lci.rivm.nl/factsheets/influenzavaccinatie
More information available at:
https://rijksvaccinatieprogramma.nl/vaccinaties/vaccinatieschema
----------------------------------------------------------------------------------------------
More information on vaccination available from:
Ministry of Health http://www.rijksoverheid.nl/onderwerpen/vaccinaties
RIVM http://www.rivm.nl/Onderwerpen/Onderwerpen/R/Rijksvaccinatieprogramma
The National Immunisation Programme in the Netherlands: https://rijksvaccinatieprogramma.nl/english
----------------------------------------------------------------------------------------------
MAJOR HISTORICAL CHANGES
2002 (September): MenC vaccination was introduced, with a catch-up campaign for all 14 months-18 years.
2003 (March): Hib was added to DTwP and IPV in a combined vaccine at 2, 3, 4 and 11 months.
2003 (March): HepB vaccination was introduced for children of parents from a hepatitis B endemic area.
2005 (January): Accellular pertussis replaced whole-cell pertussis at 2, 3, 4 and 11 months.
2006 (January): A birth dose of HepB was introduced for children born to mothers infected with hepatitis B.
2006 (June): Pneumococcal vaccination was introduced at 2, 3, 4 and 11 months.
2009 (September): HPV vaccination was introduced for girls only with three doses (0, +1 and +6 months), starting with birth cohort 1997 (additional catch-up campaign for birth cohorts 1993-1996)
2011 (May): Pneumococcal vaccination changed from 7-valent to 10-valent vaccine (for children born from 1-3-2011)
2011 (October): Transition to universal HepB vaccination (for children born from 1-8-2011), given in a combined vaccine with DTaP, IPV and Hib
2013 (November): Change to pneumococcal recommendation: 2+1 schedule instead of 3+1 schedule
2014 (January): Change to HPV recommendation. For girls under age 15, Cervarix can be adminsitered in a 2 dose schedule instead of 3 previously.
The 0-1-6-schedule in under 15's is replaced by two doses in a 0-6-schedule.
Further information for those that are currently completing HPV vaccination is available from www.prikkenteller.nl
2018: May 2018, MenC vaccination at 14 months of age has been replaced by MenACWY. From October 2018, 13-14 year olds (in the year they turn 14 years) have been vaccinated with MenACWY vaccination. A catch-up campaign was conducted in 2018-2019 targeting 14-18 year olds.
From 2021: HPV vaccination will be extended to boys
2022: HPV as a 2-dose schedule at 15 years of age (2 doses 6 months apart)
2024: introduction of Rota vaccination for those born from 1 Jan. 2024
2024: 11 months DTapIPV-Hib-HepB dose changed to 12 monts
----------------------------------------------------------------------------------------------
Date of last update: 4 February 2026
----------------------------------------------------------------------------------------------